share_log

YS Biopharma | 20-F: Registration statement / Annual report / Transition report

SEC announcement ·  Jul 26, 2023 16:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more